查詢結果分析
來源資料
相關文獻
- Improvement of Outcomes and Tapering off Corticosteroids in Patients with Chronic Obstructive Airway Disease Using Spirometry Measurements
- 氣喘病童使用皮質類固醇的安全性
- Effects of Corticosteroid--Inhalation Therapy on Lung Ventilation and Alveolar Permeability in Asthma Using TC-99M Dtpa Radioaerosol Inhalation Lung Scintigraphy
- 全身性類固醇治療慢性阻塞性肺疾病急性發作的最佳治療劑量--文獻回顧暨實證醫學證據
- 慢性阻塞性肺疾病的居家護理
- 從安保觀點看冷戰後日本對中共的政策
- 如何改善老年人氣喘病的療效
- 慢性鼻竇炎會增加氣喘病童呼吸道的敏感度
- Recent Advances in the Understanding of Childhood Asthma
- 氣喘病的中醫藥治療與預防
頁籤選單縮合
題 名 | Improvement of Outcomes and Tapering off Corticosteroids in Patients with Chronic Obstructive Airway Disease Using Spirometry Measurements=肺功能檢查在慢性阻塞性呼吸道疾病上的臨床重要性 |
---|---|
作 者 | 李岡遠; 楊朝凱; 羅友倫; 蕭世欣; 王圳華; 郭漢彬; | 書刊名 | 胸腔醫學 |
卷 期 | 16:1 2001.03[民90.03] |
頁 次 | 頁14-21 |
分類號 | 415.4 |
關鍵詞 | 慢性阻塞性呼吸道疾病; 氣喘病; 慢性阻塞性肺疾病; 呼吸量計; 皮質類固醇; 病人結果; 指導方針; Chronic obstructive airway disease; Asthma; Spirometry; Corticosteroids; Patient outcomes; International guidelines; |
語 文 | 英文(English) |
中文摘要 | 國際間治療氣喘病和慢性阻塞性肺疾病的指導方針隊建議將呼吸量計的測量列為診治依據並且需定其追蹤。為了解這樣的處置策略是否有助於藥物使用的正確引導以及病情的控制,在這個回溯性的研究中我們統計了236個從12到99歲的在胸腔科門診定期追診斷為氣喘病或慢性阻門性肺疾病的病人資料。依病歷記載是否完全依循指導方針之建議使用呼吸量計將病人分為「非肺功能」及「肺功能」2組。然後分析其急診就醫和住院次數,以及當時和一年前吸入型及口服皮質類固醇之用量。其中只有103(43.7%)人完全依照指導方針使用呼吸量計。「非肺功能」組的病人有明顯較高的急診就醫和住院次數(分別為0.28±0.06對0.02±0.01及0.11±0.03對0.02±0.01;p<0.001及p<0.014)。其初始每日吸入型皮質類固醇之用量較「肺功能」組的病人低(529.3±45.7對1033.0±52.9μg, 之budesonide, p<0.01),而口服皮質類固醇則沒有差別(3.8±0.5對4.5±0.9 mg之prednisolone, P=0.251)。一年後2種藥物在「肺功能」組的成人都成功地減量(分別為906.8±52.9μg, p=0.04及1.5±0.5mg, p<0.001)而「非肺功能」組則不然(分別為517.3±45.3μg, p=0.689及4.2±0.5mg, p=0.335)。我們的結論是胸腔科醫師對遵循國際間治療氣喘病和慢性阻塞性肺疾病的指導方針使用呼吸量計的情況並不理想。而完全依循這些指導方針使用呼吸量計確實可以達到針對每一個病人開立較為適當的藥物並成功地減輕到符合病情的最低劑量,終而改善病人結果的目的。 |
英文摘要 | Interational guidelines suggest using spirometry for the diagnosis and monitoring of disease severity in asthma and chronic obstructive pulmonary disease (COPD). We conducted a retropective study of patients with diagnoses of chronic obstructive airway diseases (COAD), including asthma and COPD, to investigate whether regular monitoring with pulmonary function tests can guide the tapering-off of corticosteroids and improve the outcomes of emergency visits or hospitalizations. A total of 236 patients were enrolled and divided into a regular follow-up with pulmonary function tests (PFT) group and a no regular follow-up with pulmonary function tests (non-PFT)group. Only 103 (43.7%) patients had been ordered spirometry measurements, based on the suggestion of the international guidelines. Patients in the non-PFT group had higher frequencles of emergency visits and hospitalizations than those in the PFT group (0.28±0.06 vs. 0.02±0.01 and 0.11±0.03 vs. 0.02±0.01 per person-year; p<0.001 and p<0.05, respectively). Compared with the non-PFT group patients, the initial daily doses of inhaled corticosteroids of patients in the PFT group were significantly hgiher, but could be tapered off successfully after a one-year treatment (from 1033.0±56.2 to 906.8±52.9μg, p<0.01). However, the daily dose of inhaled steroids did not change in the non-PFT group (from 529.3±45.7 to 517.3±45.3μg) after did tear if treatment. Although the initial doses of oral corticosteroids did not differ between the two groups, a successful reduction of the medications occurred only in the PFT group (from 4.5±0.9 to 1.5±0.5 mg, p<0.001). |
本系統中英文摘要資訊取自各篇刊載內容。